Literature DB >> 1698794

Evidence for involvement of a nuclear envelope-associated RNA helicase activity in nucleocytoplasmic RNA transport.

H C Schröder1, D Ugarkovic, P Langen, M Bachmann, A Dorn, Y Kuchino, W E Müller.   

Abstract

It seems well established that translocation of at least some mRNAs through the nuclear pore is (1) an energy-dependent process, and (2) dependent on the presence of the poly(A) segment attached to most mRNA species. We describe that RNA helicase (RNA duplex unwindase) activity is present in a nuclear envelope (NE) preparation, which also appears to be involved in nucleocytoplasmic RNA transport. This activity unwinds RNA: RNA hybrids. The helicase has a pH optimum of 7.5 and a temperature optimum of 30 degrees C. Applying the sealed NE vesicle system, it was shown that duplex RNA species are readily released from the vesicles in an unidirectional manner, in contrast to single-stranded RNA, which is much slower transported into the extravesicular space. Attachment of a poly(A) segment to the RNA duplex additionally increases the efflux rate of this RNA. Efflux of duplex RNA but not efflux of single-stranded RNA was strongly inhibited by formycin B 5'-triphosphate. Our results suggest that, besides poly(A), duplex structures, if present in a given RNA, modulate and control the export of RNA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698794     DOI: 10.1002/jcp.1041450119

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  2 in total

1.  A DEAD-box-family protein is required for nucleocytoplasmic transport of yeast mRNA.

Authors:  S Liang; M Hitomi; Y H Hu; Y Liu; A M Tartakoff
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

Review 2.  Cell-to-cell movement of plant viruses. Insights from amino acid sequence comparisons of movement proteins and from analogies with cellular transport systems.

Authors:  A R Mushegian; E V Koonin
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.